ATM and cancer: Estimates of specific cancer risks are emerging, and for gastric cancer, the reported risk conferred by heterozygous ATM PVs is up to three times higher than in the general population (odds ratio (OR) of 2.97; 95% CI, 1.66–5.31) [11].